Knowledge Obtained from an Elderly Case of Japanese Encephalitis

The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fi...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine 2016/09/01, Vol.55(17), pp.2487-2490
Main Authors: Itoh, Kyoko, Iwamoto, Kazuhide, Satoh, Yu, Fujita, Tomoaki, Takahashi, Kenta, Katano, Harutaka, Hasegawa, Hideki, Takasaki, Tomohiko, Tando, So, Fushiki, Shinji
Format: Article
Language:English
Subjects:
Aged
Antibodies, Viral - immunology
Biopsy
Encephalitis, Japanese - diagnosis
Humans
Japan
Japanese encephalitis
magnetic resonance imaging
Male
multi-virus real-time PCR
neutralizing antibody
pathology
Real-Time Polymerase Chain Reaction
vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3
cites cdi_FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3
container_end_page 2490
container_issue 17
container_start_page 2487
container_title Internal Medicine
container_volume 55
creator Itoh, Kyoko
Iwamoto, Kazuhide
Satoh, Yu
Fujita, Tomoaki
Takahashi, Kenta
Katano, Harutaka
Hasegawa, Hideki
Takasaki, Tomohiko
Tando, So
Fushiki, Shinji
description The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.
doi_str_mv 10.2169/internalmedicine.55.6646
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837333747</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1816634962</sourcerecordid><originalsourceid>FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EoqXwCyhLNil-xHayA1XlWakbWFuOPWmDnAd2KtS_x1VLF4gFm7GlOXNndBBKCJ5SIorbuh3At9o1YGtTtzDlfCpEJk7QmLCsSCVl_BSNcUHylMYyQhchfGDMclnQczSikueYcz5Gd69t9-XAriBZloOOWTapfNckuk3mzoJ322SmAyRdlbzoXrcQ__PWQL_Wrh7qcInOKu0CXB3eCXp_mL_NntLF8vF5dr9IjSBySKsSssJmnFJsbSENzzXOClZyS8AYIUk8LpOWGk6hKjWTnBUUSy1LmWEuNJugm31u77vPDYRBNXUw4Fw8qdsERXImGWMyk_9AiRBRk6ARzfeo8V0IHirV-7rRfqsIVjvV6rdqxbnaqY6j14ctmzI2j4M_biOw3AMfYdArOALaD7Vx8Gcykbt6WHEkzVp7BS37Btovm0I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1816634962</pqid></control><display><type>article</type><title>Knowledge Obtained from an Elderly Case of Japanese Encephalitis</title><source>Open Access: PubMed Central</source><creator>Itoh, Kyoko ; Iwamoto, Kazuhide ; Satoh, Yu ; Fujita, Tomoaki ; Takahashi, Kenta ; Katano, Harutaka ; Hasegawa, Hideki ; Takasaki, Tomohiko ; Tando, So ; Fushiki, Shinji</creator><creatorcontrib>Itoh, Kyoko ; Iwamoto, Kazuhide ; Satoh, Yu ; Fujita, Tomoaki ; Takahashi, Kenta ; Katano, Harutaka ; Hasegawa, Hideki ; Takasaki, Tomohiko ; Tando, So ; Fushiki, Shinji</creatorcontrib><description>The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.55.6646</identifier><identifier>PMID: 27580555</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Aged ; Antibodies, Viral - immunology ; Biopsy ; Encephalitis, Japanese - diagnosis ; Humans ; Japan ; Japanese encephalitis ; magnetic resonance imaging ; Male ; multi-virus real-time PCR ; neutralizing antibody ; pathology ; Real-Time Polymerase Chain Reaction ; vaccination</subject><ispartof>Internal Medicine, 2016/09/01, Vol.55(17), pp.2487-2490</ispartof><rights>2016 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3</citedby><cites>FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27580555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Itoh, Kyoko</creatorcontrib><creatorcontrib>Iwamoto, Kazuhide</creatorcontrib><creatorcontrib>Satoh, Yu</creatorcontrib><creatorcontrib>Fujita, Tomoaki</creatorcontrib><creatorcontrib>Takahashi, Kenta</creatorcontrib><creatorcontrib>Katano, Harutaka</creatorcontrib><creatorcontrib>Hasegawa, Hideki</creatorcontrib><creatorcontrib>Takasaki, Tomohiko</creatorcontrib><creatorcontrib>Tando, So</creatorcontrib><creatorcontrib>Fushiki, Shinji</creatorcontrib><title>Knowledge Obtained from an Elderly Case of Japanese Encephalitis</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.</description><subject>Aged</subject><subject>Antibodies, Viral - immunology</subject><subject>Biopsy</subject><subject>Encephalitis, Japanese - diagnosis</subject><subject>Humans</subject><subject>Japan</subject><subject>Japanese encephalitis</subject><subject>magnetic resonance imaging</subject><subject>Male</subject><subject>multi-virus real-time PCR</subject><subject>neutralizing antibody</subject><subject>pathology</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>vaccination</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkMtOwzAQRS0EoqXwCyhLNil-xHayA1XlWakbWFuOPWmDnAd2KtS_x1VLF4gFm7GlOXNndBBKCJ5SIorbuh3At9o1YGtTtzDlfCpEJk7QmLCsSCVl_BSNcUHylMYyQhchfGDMclnQczSikueYcz5Gd69t9-XAriBZloOOWTapfNckuk3mzoJ322SmAyRdlbzoXrcQ__PWQL_Wrh7qcInOKu0CXB3eCXp_mL_NntLF8vF5dr9IjSBySKsSssJmnFJsbSENzzXOClZyS8AYIUk8LpOWGk6hKjWTnBUUSy1LmWEuNJugm31u77vPDYRBNXUw4Fw8qdsERXImGWMyk_9AiRBRk6ARzfeo8V0IHirV-7rRfqsIVjvV6rdqxbnaqY6j14ctmzI2j4M_biOw3AMfYdArOALaD7Vx8Gcykbt6WHEkzVp7BS37Btovm0I</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Itoh, Kyoko</creator><creator>Iwamoto, Kazuhide</creator><creator>Satoh, Yu</creator><creator>Fujita, Tomoaki</creator><creator>Takahashi, Kenta</creator><creator>Katano, Harutaka</creator><creator>Hasegawa, Hideki</creator><creator>Takasaki, Tomohiko</creator><creator>Tando, So</creator><creator>Fushiki, Shinji</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20160101</creationdate><title>Knowledge Obtained from an Elderly Case of Japanese Encephalitis</title><author>Itoh, Kyoko ; Iwamoto, Kazuhide ; Satoh, Yu ; Fujita, Tomoaki ; Takahashi, Kenta ; Katano, Harutaka ; Hasegawa, Hideki ; Takasaki, Tomohiko ; Tando, So ; Fushiki, Shinji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Antibodies, Viral - immunology</topic><topic>Biopsy</topic><topic>Encephalitis, Japanese - diagnosis</topic><topic>Humans</topic><topic>Japan</topic><topic>Japanese encephalitis</topic><topic>magnetic resonance imaging</topic><topic>Male</topic><topic>multi-virus real-time PCR</topic><topic>neutralizing antibody</topic><topic>pathology</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Itoh, Kyoko</creatorcontrib><creatorcontrib>Iwamoto, Kazuhide</creatorcontrib><creatorcontrib>Satoh, Yu</creatorcontrib><creatorcontrib>Fujita, Tomoaki</creatorcontrib><creatorcontrib>Takahashi, Kenta</creatorcontrib><creatorcontrib>Katano, Harutaka</creatorcontrib><creatorcontrib>Hasegawa, Hideki</creatorcontrib><creatorcontrib>Takasaki, Tomohiko</creatorcontrib><creatorcontrib>Tando, So</creatorcontrib><creatorcontrib>Fushiki, Shinji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Itoh, Kyoko</au><au>Iwamoto, Kazuhide</au><au>Satoh, Yu</au><au>Fujita, Tomoaki</au><au>Takahashi, Kenta</au><au>Katano, Harutaka</au><au>Hasegawa, Hideki</au><au>Takasaki, Tomohiko</au><au>Tando, So</au><au>Fushiki, Shinji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Knowledge Obtained from an Elderly Case of Japanese Encephalitis</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>55</volume><issue>17</issue><spage>2487</spage><epage>2490</epage><pages>2487-2490</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>27580555</pmid><doi>10.2169/internalmedicine.55.6646</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2016/09/01, Vol.55(17), pp.2487-2490
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_1837333747
source Open Access: PubMed Central
subjects Aged
Antibodies, Viral - immunology
Biopsy
Encephalitis, Japanese - diagnosis
Humans
Japan
Japanese encephalitis
magnetic resonance imaging
Male
multi-virus real-time PCR
neutralizing antibody
pathology
Real-Time Polymerase Chain Reaction
vaccination
title Knowledge Obtained from an Elderly Case of Japanese Encephalitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A43%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Knowledge%20Obtained%20from%20an%20Elderly%20Case%20of%20Japanese%20Encephalitis&rft.jtitle=Internal%20Medicine&rft.au=Itoh,%20Kyoko&rft.date=2016-01-01&rft.volume=55&rft.issue=17&rft.spage=2487&rft.epage=2490&rft.pages=2487-2490&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.55.6646&rft_dat=%3Cproquest_cross%3E1816634962%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c617t-fbe49d45220dd97c58a0493b5d1ecc67100347d2c52efba37539207a7b74056a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1816634962&rft_id=info:pmid/27580555&rfr_iscdi=true